Incident type 2 diabetes mellitus in African American and white adults: The atherosclerosis risk in communities study

JAMA

Volumn 283, Issue 17, 2000, Pages 2253-2259

  Brancati, Frederick L ^a,b,c   Kao, W H Linda ^b   Folsom, Aaron R ^d   Watson, Robert L ^d   Szklo, Moyses ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; CAUCASIAN; CLINICAL TRIAL; COMMUNITY; DIET; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RACE DIFFERENCE; RISK FACTOR; SELF REPORT; SMOKING; UNITED STATES;

EID: 0034600265     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.17.2253     Document Type: Article

References (35)

1. Geiss L, Herman W, Smith P. Mortality in non-insulin-dependent diabetes. In: National Diabetes Data Group, ed. Diabetes in America. Bethesda, Md: US Dept of Health and Human Services, Public Health Service, National Institutes of Health; 1995;233-257.
2. American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care. 1998;21:296-309.
3. Kenny SJ, Aubert RE, Geiss LS. Prevalence and incidence of non-insulin-dependent diabetes. In: National Diabetes Data Group, ed. Diabetes in America. Bethesda, Md: US Dept of Health and Human Services, Public Health Service, National Institutes of Health; 1995:47-68.
4. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. Diabetes Care. 1998; 21:518-524.
5. Lipton RB, Liao Y, Cao G, Cooper RS, McGee D. Determinants of incident non-insulin-dependent diabetes mellitus among blacks and whites in a national sample: The NHANES I Epidemiologic Follow-up Study [published correction appears in Am J Epidemiol. 1994; 139:964]. Am J Epidemiol. 1993;138:826-839.
6. Resnick HE, Valsania P, Halter JB, Lin X. Differential effects of BMI on diabetes risk among black and white Americans. Diabetes Care. 1998;21:1828-1835.
7. Tull ES, Roseman JM. Diabetes in African Americans. In: National Diabetes Data Group, ed. Diabetes in America. Bethesda, Md: US Dept of Health and Human Services, Public Health Service, National Institutes of Health; 1995:613-630.
8. Cowie CC, Harris MI, Silverman RE, Johnson EW, Rust KF. Effect of multiple risk factors on differences between blacks and whites in the prevalence of non-insulin-dependent diabetes mellitus in the United States. Am J Epidemiol. 1993;137:719-732.
9. O'Brien TR, Flanders WD, Decoufle P, Boyle CA, DeStefano F, Teutsch S. Are racial differences in the prevalence of diabetes in adults explained by differences in obesity [published correction appears in JAMA. 1990;263:1496]? JAMA. 1989;262:1485-1488.
10. Brancati FL, Whelton PK, Kuller LH, Klag MJ. Diabetes mellitus, race, and socioeconomic status: a population-based study. Ann Epidemiol. 1996;6:67-73.
11. Pavlik VN, Nichaman MZ, Vallbona C. NIDDM incidence in a tri-ethnic population of diagnosed hypertensives. Ethn Dis. 1996;6:213-223.
12. Shaten BJ, Smith GD, Kuller LH, Neaton JD. Risk factors for the development of type II diabetes among men enrolled in the usual care group of the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993; 16:1331-1339.
13. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129:687-702.
14. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982; 36:936-942.
15. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122: 51-65.
16. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem. 1983;29:1075-1080.
17. Nagele U, Hagele EO, Sauer G, et al. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem. 1984;22:165-174.
18. Warnick GR, Benderson JM, Albers JJ. Quantitation of high-density lipoprotein subclasses after separation by dextran sulfate and Mg2+ precipitation [abstract]. Clin Chem. 1982;28:1574.
19. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
20. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1999;22:S5-S19.
21. Holbrook TL, Barrett-Connor E, Wingard DL. A prospective, population-based study of alcohol use and non-insulin-dependent diabetes mellitus. Am J Epidemiol. 1990;132:902-909.
22. Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ. 1995; 310:555-559.
23. Breslow NE, Day NE. Statistical Methods in Cancer Research. Lyon, France: International Agency for Research on Cancer, IARC Publications: 1990;76-78. Publication 32.
24. Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. N Engl J Med. 2000;342:905-912.
25. Kaufman JS, Cooper RS, McGee DL. Socioeconomic status and health in blacks and whites: the problem of residual confounding and the resiliency of race. Epidemiology. 1997;8:621-628.
26. Bonham GS, Brock DB. The relationship of diabetes with race, sex, and obesity. Am J Clin Nutr. 1985; 41:776-783.
27. McPhillips JB, Barrett-Connor E, Wingard DL, Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol. 1990;131:443-453.
28. Burke JP, Williams K, Gaskill SP, Hazuda HP, Haffner SM, Stern MP. Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. Arch Intern Med. 1999;159: 1450-1456.
29. Melton LJ III, Palumbo PJ, Chu DP. Incidence of diabetes mellitus by clinical type. Diabetes Care. 1983; 6:75-86.
30. Stern MP. Do non-insulin-dependent diabetes mellitus and cardiovascular disease share common antecedents? Ann Intern Med. 1996;124(1 pt 2):110-116.
31. Schmidt Ml, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss C, for the Atherosclerosis Risk in Communities Study Investigators. A metabolic syndrome in whites and African-Americans: The Atherosclerosis Risk in Communities Baseline Study. Diabetes Care. 1996;19:414-418.
32. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [published correction appears in Lancet. 1999;354: 602]. Lancet. 1998;352:837-853.
33. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 [published correction appears in BMJ. 1999;318:29]. BMJ. 1998;317:703-713.
34. Lei HH, Coresh J, Shuldiner AR, Boerwinkle E, Brancati FL. Variants of the insulin receptor substrate-1 and fatty acid binding protein-2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes. 1999;48:1868-1872.
35. Hales CN, Barker DJ, Clark PM, et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ. 1991;303:1019-1022.